Lexicon Pharmaceuticals | LXRX - DÍVIDA

Preço das Ações
2.34
Mudança Diária
0.34 16.75%
Mensal
32.67%
Anual
233.10%
Q2 Previsão
1.96




DÍVIDA Alterar Data
Abbott USD 13.86B 919M 2025-12
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
AstraZeneca USD 33.92B 4.3B 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.5B 3.6M 2025-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Halozyme Therapeutics USD 2.14B 631.87M 2025-12
Illumina USD 2.55B 23M 2025-12
Insmed USD 727.62M 275K 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 47.93B 2.14B 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
MacroGenics USD 37.01M 238K 2025-09
MannKind USD 367.44M 247.53M 2025-12
Merck USD 49.34B 7.97B 2025-12
Moderna USD 1.31B 571M 2025-12
Novartis USD 47B 11.62B 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12